Using Human Genetics to Find Effective Treatments

Our mission is to more efficiently identify new therapies for serious diseases with unmet medical need

The Vanderbilt Institute for Clinical and Translational Research (VICTR) and the Accelerating Drug Discovery & Repurposing Incubator (ADDRI) leverage Vanderbilt resources to discover novel gene/disease associations and rapidly launch and execute drug development programs. ADDRI is a multidisciplinary think tank of experts in various therapeutic areas: Basic scientists, clinicians, clinical researchers, technology transfer, legal/regulatory, statistics, biomedical informatics, and information science.